Characteristics and clinical outcomes of COVID ‐19 patients with pulmonary disorders: A single‐center, retrospective observational studyCritical Care Medicine Published on 2022-02-222022-11-01 Journal: Health Science Reports [Category] COVID-19, [키워드] admitted to ICU Asthma Care Clinical characteristics Clinical outcome Coinfection Comorbidity conditions conducted coronavirus disease COVID COVID‐19 COVID‐19 critical care patient death demographic characteristics Diabetes Mellitus died Disease progression disorder Frame hypertension ICU ICU admission intensive care intubation invasive ventilation Lung disease males management mechanical ventilation Mortality mortality rate objective outcome outcomes Patient pulmonary disease renal impairment required Respiratory disease Result retrospective Retrospective study Secondary infection secondary infections significantly Tocilizumab [DOI] 10.1002/hsr2.525 PMC 바로가기 [Article Type] Critical Care Medicine
Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic TargetsCOVID-19에서의 신장 손상: 역학, 분자 기전 및 잠재적 치료 표적Review Published on 2022-02-172022-09-10 Journal: International Journal of Molecular Sciences [Category] MERS, 변종, [키워드] Acute kidney injury Affect AKI caused cellular COVID-19 death effective therapy Effective vaccines Epidemiology focus Infection Injury Kidney disease kidneys manifestation mechanism molecular molecular mechanism multiple organs outcomes pandemic pathogenesis of SARS-CoV-2 Pneumonia Potential presenting renal impairment SARS-CoV-2 SARS-COV-2 infection severe COVID-19 target the disease therapeutic target therapy variants of SARS-CoV-2 Viral viral entry [DOI] 10.3390/ijms23042242 PMC 바로가기 [Article Type] Review
Effects of Renal Impairment on the Pharmacokinetics of Abrocitinib and Its MetabolitesSpecial Populations Published on 2022-02-152024-09-04 Journal: Journal of clinical pharmacology [Category] 대상포진, [키워드] abrocitinib active moiety atopic dermatitis pharmacokinetics renal impairment [DOI] 10.1002/jcph.1980 PMC 바로가기 [Article Type] Special Populations
Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort studyObservational Study Published on 2022-02-122022-10-04 Journal: BMC Geriatrics [Category] 임상, [키워드] 28-day mortality 95%CI adjusted adjusted odds ratio Admission analysed chronic kidney failure COPE COVID-19 Cox proportional hazard demographic characteristics demographic data Dose-response EGFR eight European Evidence General population glomerular filtration rate Hospital stay hospitalised in-hospital mortality increased mortality independent Logistic regression median Mortality multicentre Observational cohort study Older age older patient outcome Patient prevalent Primary outcome prognostic reduced renal function renal impairment Result secondary Stage supplementary material time-to-event analysis was measured with COVID-19 [DOI] 10.1186/s12877-022-02782-5 PMC 바로가기 [Article Type] Observational Study
Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort studyObservational Study Published on 2022-02-122022-10-27 Journal: BMC Geriatrics [Category] COVID-19, [키워드] 28-day mortality 95%CI adjusted adjusted odds ratio Admission analysed chronic kidney failure COPE COVID-19 Cox proportional hazard demographic characteristics demographic data Dose-response EGFR eight European Evidence General population glomerular filtration rate Hospital stay hospitalised in-hospital mortality increased mortality independent Logistic regression median Mortality multicentre Observational cohort study Older age older patient outcome Patient prevalent Primary outcome prognostic reduced renal function renal impairment Result secondary Stage supplementary material time-to-event analysis was measured with COVID-19 [DOI] 10.1186/s12877-022-02782-5 PMC 바로가기 [Article Type] Observational Study
Prognostic value of estimated glomerular filtration rate in hospitalised older patients (over 65) with COVID-19: a multicentre, European, observational cohort studyObservational Study Published on 2022-02-122022-10-27 Journal: BMC Geriatrics [Category] Coronavirus, COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] 28-day mortality 95%CI adjusted adjusted odds ratio Admission analysed chronic kidney failure COPE COVID-19 Cox proportional hazard demographic characteristics demographic data Dose-response EGFR eight European Evidence General population glomerular filtration rate Hospital stay hospitalised in-hospital mortality increased mortality independent Logistic regression median Mortality multicentre Observational cohort study Older age older patient outcome Patient prevalent Primary outcome prognostic reduced renal function renal impairment Result secondary Stage supplementary material time-to-event analysis was measured with COVID-19 [DOI] 10.1186/s12877-022-02782-5 PMC 바로가기 [Article Type] Observational Study
Impact of COVID-19 on Renal Function: A Multivariate Analysis of Biochemical and Immunological Markers in PatientsInfectious Disease Published on 2022-02-102022-10-31 Journal: Cureus [Category] COVID-19, [키워드] ACE2 Admission albumin angiotensin-converting enzyme 2 Biomarker Blood C-reactive protein CAD Care cells cerebrovascular accident changes Chest CT chronic obstructive college comorbid condition comorbid conditions condition conducted contributed COPD Coronary artery disease coronavirus disease COVID-19 COVID-19 patient COVID-19 patients creatinine CRP CT chest demonstrated direct infection disease effort evaluate expression Factor ferritin group hypertension Impact inflammatory markers kidney Kidney injury laboratory diagnosis Mild moderate Multiple multiple organ failure multivariate NLR P-value pandemic Patient Potassium Protein pulmonary disease renal function renal function tests renal impairment Result Retrospective cross-sectional study SARS-CoV-2 serum biomarkers sodium the patient Treatment type 2 diabete urea were recorded [DOI] 10.7759/cureus.22076 PMC 바로가기 [Article Type] Infectious Disease
Response to Vaccination Against SARS-CoV-2 in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal InvolvementMedicine Published on 2022-01-202022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] affected Against age ANCA-associated vasculitis antibody Blood blood sample booster vaccination cohort of patient collected data COVID-19 COVID-19 vaccination COVID-19 vaccine cytoplasmic disease dose doses evaluated Evidence females first dose fluorescence intensity high risk hospital Immunosuppression Involvement IQR Local median National offer Patient Patient care patient cohorts Pfizer public health reduced regimen renal renal disease renal impairment Renal involvement response response to vaccination Result retrospective risk of COVID-19 rituximab SARS-CoV-2 second dose Seroconversion seroconversion response seroconvert subgroup analysis Support treated Treatment vaccination Vaccine was measured [DOI] 10.3389/fmed.2021.817845 PMC 바로가기 [Article Type] Medicine
New Onset Biopsy-Proven Nephropathies after COVID VaccinationCOVID 예방 접종 후 새로운 발병 생검으로 입증된 신병증Article Published on 2022-01-012022-09-11 Journal: American journal of nephrology [Category] 변종, [키워드] abnormality Acute kidney injury Administered appearance benefit causal relationship Cohort common disease Corticosteroid Corticosteroids COVID COVID vaccination COVID-19 vaccine de novo declined determine Diagnosis dose focal segmental glomerulosclerosis followed by glomerular Glomerulopathies glomerulosclerosis Hemodialysis highlight Hospitalized IgA nephropathy immune response immunosuppressants Injury Interstitial nephritis Kidney biopsy lupus erythematosus membranoproliferative glomerulonephritis Membranous nephropathy minimal change disease national health system nephropathy New Onset pandemic Patient patients pharmacovigilance pressure renal renal biopsy renal function renal impairment renal insufficiency SARS-CoV-2 SARS-CoV-2 vaccination severity suggested systemic lupus erythematosus the patient Treatment Trigger Two patient two patients unit vaccination Vaccine Vasculitis [DOI] 10.1159/000523962 PMC 바로가기 [Article Type] Article
Antineutrophil Cytoplasmic Antibody-associated Vasculitis after COVID-19 Vaccination with Pfizer-BioNTechArticle Published on 2022-01-012022-11-15 Journal: Internal medicine (Tokyo, Japan) [Category] 바이오마커, 진단, [키워드] Acute kidney injury ANCA-associated vasculitis antibody coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine cytoplasmic diagnosed Fever Hemodialysis High-dose intravenous mRNA vaccine Pfizer-BioNTech Prednisolone rapidly progressive glomerulonephritis. receiving renal abnormality renal impairment reported second dose Side effect Symptom systemic symptom treated Vasculitis [DOI] 10.2169/internalmedicine.9807-22 PMC 바로가기